Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 17Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma 11Hodgkin Disease 11Myeloproliferative Disorders 9Congenital Abnormalities 9Neoplasms, Plasma Cell 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic-Phase 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Hematologic Neoplasms 5Graft vs Host Disease 5Burkitt Lymphoma 5Sezary Syndrome 4

Interventions

fludarabine phosphate 2Whole-Body Irradiation 2Therapeutics 2Cyclophosphamide 2thymoglobulin 1fosphenytoin 1fludarabine 1Thiotepa 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immunologic Deficiency Syndromes × Busulfan × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡